Forest plot for subgroup analysis on PRISMA and AMSTAR statements.Danlu, LiuJiaxin, JinJinhui, TianKehu, Yang
Forest plot describing subgroup analysis of the association between PD-L1 expression and 3-year OS of patients with esophageal cancer (A), gastric cancer (B), hepatocellular carcinoma (C) and u...
Comparison of demographic, clinical characteristics and medications between subgroup D1, group B, subgroup D2, and subgroup D3.Notes(A) Forest plot using standardized mean difference of demographic, clinical characteristics and medications for subgroup analysis. (B) Forest plot using odds ratio of de...
We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...
Preferred reporting items for systematic reviews and meta-analyses; RCT: Randomized, clinical trial; SAE: Serious adverse events; TSA: Trial sequential analysis Acknowledgements We would like to thank Sarah Louise Klingenberg, Trial Search Coordinator at Cochrane Hepato-Biliary Group for the extensive li...
The primary analysis of OS was planned to occur when 70% of the first 850 ITT patients had died. For both the primary analysis and the current Japanese subgroup analysis, OS was estimated by the Kaplan-Meier method, with 95% CIs estimated using the Brookmeyer-Crowley method. HR was ...
"dat_main.rds": Result for main analysis. "dat_sub.rds": Results for subgroup analysis "R_viz": R code for making plot Similar plots can be found in the following papers Yin K, Luo R, Wei Y, Wang F, Zhang Y, Karlson KJ, Zhang Z, Reardon MJ, Dobrilovic N. Survival outcomes ...
Advances in secondary data analysis of survival data has been made by Guyot et al. [1]. This enables retrieval of individual patient data (IPD) from reported Kaplan-Meier (KM) plots [2, 3]. However, this is only amenable for KM plots presented in the original publication. Often, subgrou...
analysis. Any statistical heterogeneity that is detected in results must also be taken into account when interpreting the results, as this can affect the generalisability of the conclusiosn that can be drawn. There are different ways to assess this: Visually inspect the forest plot to look...
The results of the analysis/analyses then allow for classifying the patient into the DLBCL subgroups defined in accordance with the invention. In other words, results of the analysis/analyses then allow for classifying whether the patient is a “patient defined herein”. This may be the other ...